Karo Pharma News and Activities

View the org chart displaying its 17 main executives

Most searched biographies at Karo Pharma

• Christoffer Lorenzen, Chief Executive Officer
• Esad Toric, Managing Director, Nordics and Baltics
• Konstanze Gallinatus, Chief Transformation Officer

Popular executive movements at Karo Pharma

• Tejesh Adavi, Digital Marketplaces Sales Director, has left the company  (posted on April 8 2026).
• Karine Martin will join the company as Chief Financial Officer in Apr. 2026  (posted on March 17 2026).
• Egil Madsen, Chief Financial Officer, has left the company  (posted on March 17 2026).

Create your alert
to follow the executive moves at Karo Pharma.

Karo Pharma has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Karo Pharma

• Press releases - Karo Healthcare
• News - Karo Healthcare
• News - Karo Healthcare
• News - Karo Healthcare
• Pressmeddelanden | Karo Pharma
• Press Releases | Karo Pharma
• Pressmeddelanden | Karo Pharma
• Press releases | Karo Pharma
• View more press releases Close

Social media about Karo Pharma

• Karo Pharma on Wikipedia, Google News & Yahoo Finance
• Karo Pharma on LinkedIn, X (Twitter) & YouTube